JP2007511837A5 - - Google Patents

Download PDF

Info

Publication number
JP2007511837A5
JP2007511837A5 JP2006539990A JP2006539990A JP2007511837A5 JP 2007511837 A5 JP2007511837 A5 JP 2007511837A5 JP 2006539990 A JP2006539990 A JP 2006539990A JP 2006539990 A JP2006539990 A JP 2006539990A JP 2007511837 A5 JP2007511837 A5 JP 2007511837A5
Authority
JP
Japan
Prior art keywords
fragment
post
capture agent
fluid
pet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006539990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007511837A (ja
Filing date
Publication date
Priority claimed from US10/712,425 external-priority patent/US7460960B2/en
Application filed filed Critical
Publication of JP2007511837A publication Critical patent/JP2007511837A/ja
Publication of JP2007511837A5 publication Critical patent/JP2007511837A5/ja
Pending legal-status Critical Current

Links

JP2006539990A 2003-11-13 2004-11-15 プロテオームエピトームタグ及びそれらのタンパク質修飾分析における利用方法 Pending JP2007511837A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/712,425 US7460960B2 (en) 2002-05-10 2003-11-13 Proteome epitope tags and methods of use thereof in protein modification analysis
PCT/US2004/038283 WO2005050223A2 (en) 2003-11-13 2004-11-15 Proteome epitope tags and methods of use thereof in protein modification analysis

Publications (2)

Publication Number Publication Date
JP2007511837A JP2007511837A (ja) 2007-05-10
JP2007511837A5 true JP2007511837A5 (enExample) 2008-01-10

Family

ID=34619853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006539990A Pending JP2007511837A (ja) 2003-11-13 2004-11-15 プロテオームエピトームタグ及びそれらのタンパク質修飾分析における利用方法

Country Status (6)

Country Link
US (2) US7460960B2 (enExample)
EP (1) EP1683065A2 (enExample)
JP (1) JP2007511837A (enExample)
AU (2) AU2004292226B2 (enExample)
CA (1) CA2545899A1 (enExample)
WO (1) WO2005050223A2 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113744A1 (en) * 2001-05-11 2003-06-19 O' Toole Margot M. Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
US7695926B2 (en) 2001-07-10 2010-04-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting receptor-ligand interactions in single cells
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
AU2002365421A1 (en) 2001-07-10 2003-09-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
FI118061B (fi) * 2001-09-24 2007-06-15 Beanor Oy Menetelmä ja bioanturi analyysiä varten
FI115166B (fi) * 2001-12-31 2005-03-15 Biofons Oy Diagnostisia menetelmiä
IL165033A0 (en) 2002-05-07 2005-12-18 Univ California Bioactivation of particles
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US7460960B2 (en) 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7632686B2 (en) * 2002-10-03 2009-12-15 Anderson Forschung Group High sensitivity quantitation of peptides by mass spectrometry
US7846748B2 (en) * 2002-12-02 2010-12-07 The University Of North Carolina At Chapel Hill Methods of quantitation and identification of peptides and proteins
WO2005032453A2 (en) * 2003-04-28 2005-04-14 Sequoia Pharmaceuticals, Inc. Antiviral agents for the treatment, control and prevention of infections by coronaviruses
US7425700B2 (en) * 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
WO2005053649A1 (en) * 2003-11-05 2005-06-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Biofunctionalized quantum dots for biological imaging
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
EP1766388A4 (en) * 2004-06-09 2008-08-20 Anderson Forschung Group Llc STABLE ISOTOPES MARKED POLYPEPTIDE STANDARDS FOR PROTEIN QUANTIFICATION
WO2006093516A2 (en) 2004-06-22 2006-09-08 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
US20060240227A1 (en) * 2004-09-23 2006-10-26 Zhijun Zhang Nanocrystal coated surfaces
ATE541821T1 (de) * 2004-10-12 2012-02-15 Schott Ag Gemultiplexter proteinadsorptions-assay
CN101194260A (zh) * 2005-01-24 2008-06-04 利兰·斯坦福青年大学托管委员会 使用贝叶斯网络建立细胞信号传导系统模型的方法
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20060223194A1 (en) * 2005-04-01 2006-10-05 Viorica Lopez-Avila Methods of screening for post-translationally modified proteins
US20060223130A1 (en) * 2005-04-04 2006-10-05 Dan-Hui Yang Detection of post-translationally modified analytes
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
EP2402321A3 (en) * 2005-12-07 2012-02-29 Ramot at Tel Aviv University, Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
WO2007123708A2 (en) * 2006-03-31 2007-11-01 Epitome Biosystems, Inc. Post translational modification pattern analysis
US20090269773A1 (en) * 2008-04-29 2009-10-29 Nodality, Inc. A Delaware Corporation Methods of determining the health status of an individual
US20090291458A1 (en) * 2008-05-22 2009-11-26 Nodality, Inc. Method for Determining the Status of an Individual
WO2010006291A1 (en) 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
US20100099109A1 (en) * 2008-10-17 2010-04-22 Nodality, Inc., A Delaware Corporation Methods for Analyzing Drug Response
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
KR101061017B1 (ko) * 2009-10-23 2011-08-31 (주) 수파드엘릭사 암세포의 성장 및/또는 전이 억제용 약학 조성물
KR101341640B1 (ko) * 2010-02-05 2013-12-16 한국전자통신연구원 단백질 미세 구조 분석 방법 및 단백질 미세 구조 분석용 어레이
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
JPWO2012026309A1 (ja) * 2010-08-23 2013-10-28 公立大学法人横浜市立大学 抗ｐａｄ４抗体医薬の創成
WO2012027555A2 (en) 2010-08-25 2012-03-01 President And Fellows Of Harvard College Glycated cd59 peptides, their preparation, and uses thereof
US9383367B1 (en) 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
MX348592B (es) * 2011-02-10 2017-06-12 Harvard College Sustitutos de proteinas modificadas post-traduccionalmente y usos de los mismos.
US9023599B2 (en) * 2011-09-25 2015-05-05 Chang Gung Medical Foundation, Linkou Branch Method of detecting the presence of pneumococcal neuraminidases in Streptococcus pneumoniae-infected samples
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9975922B2 (en) 2013-10-21 2018-05-22 The Research Foundation For The State University Of New York Peptide inhibitor of HIV reverse transcription
CN103698509B (zh) * 2014-01-08 2017-02-08 青岛科技大学 基于纳米多孔金片电极的电化学免疫传感器对巯基乙酸的检测
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
KR101750407B1 (ko) 2014-11-10 2017-06-27 한양대학교 산학협력단 프로틴 카이네이즈 a 기질 인산화펩타이드에 결합하는 알엔에이 앱타머
US10006906B2 (en) 2015-02-27 2018-06-26 Regents Of The University Of Minnesota Detection assays and methods
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JP6548981B2 (ja) * 2015-07-14 2019-07-24 地方独立行政法人東京都立産業技術研究センター 表面プラズモン共鳴測定装置及びそのチップ
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10520514B2 (en) * 2017-02-01 2019-12-31 Korea Institute Of Science And Technology Method for monitoring post-translational modification of protein
TW201902927A (zh) 2017-04-21 2019-01-16 美商梅利特公司 糖尿病相關應用之方法及抗體
EP3404567A1 (en) * 2017-05-19 2018-11-21 Fujitsu Limited A system and a method for discovery of predicted site-specific protein phosphorylation candidates
CA3071894A1 (en) * 2017-08-04 2019-02-07 Abcam Plc Methods and compositions for the development of antibodies specific to epitope post-translational modification status
CN108776231B (zh) * 2018-09-06 2020-12-29 长沙文瀚生物技术有限责任公司 一种人尿白蛋白胶乳增强二抗竞争免疫比浊检测试剂盒及其制作和使用方法
EP3640864A1 (en) * 2018-10-18 2020-04-22 Fujitsu Limited A computer-implemented method and apparatus for inferring a property of a biomedical entity
CN110209770B (zh) * 2019-06-03 2022-04-15 北京邮电大学 一种基于策略价值网络和树搜索增强的命名实体识别方法
CA3146525A1 (en) 2019-08-05 2021-02-11 William Manning Systems and methods for sample preparation, data generation, and protein corona analysis
US12285437B2 (en) 2019-10-30 2025-04-29 The Research Foundation For The State University Of New York Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity
CN113899902B (zh) * 2020-06-22 2024-10-29 上海科技大学 一种酪氨酸磷酸酶底物鉴定方法
CN112305041B (zh) * 2020-09-15 2022-05-27 东莞东阳光医疗智能器件研发有限公司 多重定量电化学免疫传感器及其构建方法
US20230358737A1 (en) * 2020-09-24 2023-11-09 University Of Cincinnati Continuously chemically enhanced aptamer sensors
US11617741B1 (en) 2021-08-12 2023-04-04 Health Research, Inc. Method for inhibiting growth of bacteria
CN118369728A (zh) * 2021-08-25 2024-07-19 上海昂胜医疗科技有限公司 翻译后修饰启发的药物设计和筛选的系统和方法
JP2023121226A (ja) * 2022-02-21 2023-08-31 株式会社日立製作所 検体の前処理方法及びその応用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478744A (en) * 1982-01-25 1984-10-23 Sherwood Medical Company Method of obtaining antibodies
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
DE3815932A1 (de) 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
DE3773121D1 (de) 1986-11-10 1991-10-24 Progen Biotechnik Gmbh Verfahren zum identifizieren gewebstypischer, unloeslicher cytoskelettproteine.
US4970171A (en) * 1987-11-09 1990-11-13 Miles Inc. Denaturant reagents for convenient determination of hemoglobin derivatives in blood
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
US5849531A (en) * 1989-04-07 1998-12-15 University Of Saskatchewan Compositions and treatments for pneumonia in animals
US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers
US5061790A (en) * 1989-07-10 1991-10-29 Molecular Diagnostics, Inc. Oxidative denaturation of protein analytes
DE4009848A1 (de) * 1990-03-27 1991-10-02 Boehringer Mannheim Gmbh Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
DE4023945A1 (de) 1990-07-27 1992-01-30 Progen Biotechnik Gmbh Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
AU2699192A (en) * 1991-10-16 1993-05-21 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
DE69333397T2 (de) * 1992-08-27 2004-12-09 Bioclones (Proprietary) Ltd., Sandton Retro-, inverso-, und retro-inverso synthetische peptidanaloge
WO1994008597A1 (en) 1992-10-14 1994-04-28 The Scripps Research Institute Methods for the detection of antigen-specific immune complexes
US5955317A (en) * 1993-01-25 1999-09-21 Takeda Chemical Industries, Ltd. Antibodies to β-amyloids or their derivatives and use thereof
JPH07285999A (ja) 1993-03-30 1995-10-31 Prima Meat Packers Ltd Ｅｌｉｓａを用いた食品中の乳蛋白質含量の定量分析方法及びその分析用に選別されたモノクローナル抗体及びそのモノクローナル抗体の選別方法
JP3393889B2 (ja) * 1993-06-11 2003-04-07 柳川精工株式会社 無潤滑軸受の製造方法および無潤滑軸受
CA2164728A1 (en) 1993-06-22 1995-01-05 Helmut Ponta Processes for diagnosing and analysing tumours
JPH10507344A (ja) 1994-08-22 1998-07-21 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア エピトープ整列化とタンパク質制限地図作製によるタンパク質の配列決定方法
WO1996029629A2 (en) 1995-03-01 1996-09-26 President And Fellows Of Harvard College Microcontact printing on surfaces and derivative articles
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
AUPN480095A0 (en) 1995-08-15 1995-09-07 Commonwealth Scientific And Industrial Research Organisation Epitope tagging system
JP3452111B2 (ja) * 1995-11-10 2003-09-29 セイコーエプソン株式会社 インクジェット式記録ヘッド
US6420125B1 (en) * 1996-03-21 2002-07-16 Osteometer Biotech A/S Assaying fragments of collagen in body fluids
US5763158A (en) * 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5872234A (en) * 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
US6253456B1 (en) * 1997-11-17 2001-07-03 Phillip Cooksey Basketball court layout device and method
US6809184B1 (en) * 1997-12-01 2004-10-26 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
DE19802576B4 (de) 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
WO1999039210A1 (en) 1998-01-29 1999-08-05 Miller, Samuel High density arrays for proteome analysis and methods and compositions therefor
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US20020119579A1 (en) * 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US6897073B2 (en) 1998-07-14 2005-05-24 Zyomyx, Inc. Non-specific binding resistant protein arrays and methods for making the same
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
EP1147414B1 (en) 1999-01-28 2004-06-09 Universite De Geneve Method and kit for identifying or characterising polypeptides
AU773291B2 (en) 1999-03-10 2004-05-20 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The UPA, a universal protein array system
US20020090672A1 (en) * 2000-01-31 2002-07-11 Rosen Craig A. Nucleic acids, proteins, and antibodies
WO2001078652A2 (en) 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020110843A1 (en) * 2000-05-12 2002-08-15 Dumas David P. Compositions and methods for epitope mapping
JP2004504607A (ja) 2000-07-19 2004-02-12 ポインティリスト・インコーポレイテッド ネスト化ソーティングおよびハイスループットスクリーニングのための結合タンパク質およびタグのコレクションならびにそれら使用
GB0022978D0 (en) * 2000-09-19 2000-11-01 Oxford Glycosciences Uk Ltd Detection of peptides
US7142296B2 (en) * 2000-10-30 2006-11-28 Sru Biosystems, Inc. Method and apparatus for detecting biomolecular interactions
DE10054055A1 (de) 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
AU2002230419A1 (en) * 2000-11-08 2002-05-21 Science And Technology Corporation @Unm Fluorescence and fret based assays for biomolecules on beads
IL140881A0 (en) 2001-01-14 2002-02-10 Katz Emil Israel A method for identification and quantification of proteins in a biopsy or other tissue sample and a kit for use thereof
GB0103389D0 (en) * 2001-02-12 2001-03-28 Novartis Ag Organic compounds
WO2002086081A2 (en) * 2001-04-20 2002-10-31 Carnegie Mellon University Methods and systems for identifying proteins
US20030044862A1 (en) * 2001-06-22 2003-03-06 The Board Of Trustees Of The Leland Stanford Jr. University Diagnostic marker for tumor hypoxia and prognosis
EP1409714A4 (en) 2001-06-26 2004-07-28 Mds Proteomics Inc METHOD AND SYSTEM FOR IDENTIFYING KINASES, PHOSPHATASES AND SUBSTRATES THEREOF
EP1417626A2 (en) * 2001-07-13 2004-05-12 Pharmacopeia, Inc. System and method for aqueous solubility prediction
US20030143612A1 (en) 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
CA2407299A1 (en) * 2001-08-13 2003-02-13 Douglas A. Campbell Peptide sequence tags and method of using same
AU2002367935A1 (en) * 2001-10-23 2003-12-22 Sloan Kettering Institute For Cancer Research Protein micro-arrays and multi-layered affinity interaction detection
GB0200595D0 (en) 2002-01-11 2002-02-27 Oxford Glycosciences Uk Ltd Quantitation of differential expression
AU2003302118A1 (en) * 2002-05-10 2004-06-15 Epitome Biosystems, Inc. Unique recognition sequences and methods of use thereof in protein analysis
US20060014212A1 (en) * 2002-05-10 2006-01-19 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7460960B2 (en) 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7618788B2 (en) 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US20040229284A1 (en) * 2003-02-19 2004-11-18 The Regents Of The University Of California Multiplex analysis of proteins
WO2005050224A2 (en) 2003-11-13 2005-06-02 Epitome Biosystems Inc. Small molecule and peptide arrays and uses thereof
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
WO2007123708A2 (en) 2006-03-31 2007-11-01 Epitome Biosystems, Inc. Post translational modification pattern analysis

Similar Documents

Publication Publication Date Title
JP2007511837A5 (enExample)
JP6553142B2 (ja) タンパク質のグリコシル化の評価による肝臓病変の診断
CN107110867B (zh) 用于肝癌诊断的生物标记物及其用途
TWI281473B (en) Biomarkers for liver diseases and method for using same
EP0970377B1 (en) Diagnosis of epithelial cell abnormalities
JP2008509379A (ja) 活性化可能な遊離型ｐｓａの検出方法、並びに、前立腺の良性病状及び前立腺ガンの診断におけるその使用
KR102702698B1 (ko) 암의 진단용 조성물
Thierolf et al. Towards a comprehensive proteome of normal and malignant human colon tissue by 2‐D‐LC‐ESI‐MS and 2‐DE proteomics and identification of S100A12 as potential cancer biomarker
Frascione et al. Fluorogenic displacement biosensors for PSA detection using antibody-functionalised quantum dot nanoparticles
KR20110038778A (ko) 다중렉틴을 이용한 체액 유래 단백질 동정 방법 및 이 방법에 의하여 탐지된 간암 바이오마커
WO2016093567A1 (ko) 간암 진단용 바이오마커 및 그 용도
US8183004B2 (en) Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections
CN116875674A (zh) 一组预测慢加急性肝功能衰竭预后的标志物及其应用
CN112534262A (zh) 检测手足口病的方法
EP3810795A1 (en) Biomarkers for urothelial carcinoma and applications thereof
KR101832039B1 (ko) 간암 표적치료제 반응 예측용 바이오마커 및 그 용도
CN108047327B (zh) 一种检测骨关节炎的生物标志物及其应用
JP2022110148A (ja) 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
WO2023004626A1 (zh) 一种骨髓瘤生物标志物serpinf2及其应用
JP2007071645A (ja) タンパク質の測定方法
KR20170100213A (ko) 신장암 진단용 조성물과 진단 마커 검출 방법
EP1540342B1 (en) Methods and compositions for diagnosing hepatocellular carcinoma
JP5640271B2 (ja) 新規ペプチド及びその使用
WO2016093629A1 (ko) 간암 표적치료제 반응 예측용 바이오마커 및 그 용도